Reduction in the frequency of neural tube defects in splotch mice by retinoic acid

• Published in: Teratology (Philadelphia) Vol. 32; no. 1; p. 87
• Main Authors: Kapron-Brás, C M, Trasler, D G
• Format: Journal Article
• Language: English
• Published: United States 01.08.1985
• Subjects: Animals; Brain - abnormalities; Female; Fetal Resorption - chemically induced; Fetal Resorption - epidemiology; Fetus - drug effects; Gestational Age; Mice - genetics; Mice - physiology; Mice, Inbred Strains; Neural Tube Defects - epidemiology; Neural Tube Defects - genetics; Neural Tube Defects - prevention & control; Pregnancy; Spina Bifida Occulta - epidemiology; Spina Bifida Occulta - genetics; Spina Bifida Occulta - prevention & control; Tretinoin - therapeutic use
• ISSN: 0040-3709
• DOI: 10.1002/tera.1420320112

In the homozygous state, the splotch (Sp) gene causes spina bifida and exencephaly. Close to 25% of the embryos from Sp/ + X Sp/+ litters are affected. The frequency of these defects is significantly reduced by maternal treatment with 5 mg/kg retinoic acid on day 9 of gestation. There is no significant increase in the resorption frequency with this treatment, indicating that the fall in the frequency of neural tube defects is not due to differential mortality of the affected fetuses. The effects of retinoic acid are time specific, with treatment at different times on day 9 having the greatest influence on either the anterior or posterior neuropore. Treatment on day 8 with the same dose of retinoic acid causes an increase in both resorptions and neural tube defects, although only the increase in the former was significant.